Nymox Pharmaceutical Corporation (NYMXF)
USD 0.1
(23.3%)
USD 0.1
(23.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 5000.00 | 116 Thousand | 299 Thousand |
| Cost of Revenue | 11 Thousand | 12 Thousand | 12 Thousand | 13 Thousand | 67 Thousand | 141.04 Thousand |
| Gross Profit | -11 Thousand | -12 Thousand | -12 Thousand | -8000.00 | 49 Thousand | 157.95 Thousand |
| Operating Expenses | 8.33 Million | 6.64 Million | 12.49 Million | 11.71 Million | 13.37 Million | 10.79 Million |
| Selling, General and Administrative Expenses | 4.35 Million | 2.87 Million | 5.84 Million | 3.6 Million | 6 Million | 4.12 Million |
| Research and Development Expenses | 3.98 Million | 3.76 Million | 6.64 Million | 8.11 Million | 7.36 Million | 6.67 Million |
| Other Expenses | - | 113 Thousand | - | - | - | - |
| Cost and Expenses | 8.35 Million | 6.65 Million | 12.5 Million | 11.72 Million | 13.44 Million | 10.94 Million |
| Operating Income | -8.35 Million | -6.65 Million | -12.5 Million | -11.72 Million | -13.32 Million | -10.64 Million |
| Interest Expense | 61 Thousand | 43 Thousand | 39 Thousand | 42 Thousand | 38 Thousand | 18 Thousand |
| Income Tax Expense | -433 Thousand | -1.00 | - | - | -1.00 | -2.00 |
| Earnings before Tax | -8.84 Million | -6.57 Million | -12.53 Million | -11.73 Million | -13.16 Million | -10.59 Million |
| Net Income | -8.84 Million | -6.57 Million | -12.53 Million | -11.73 Million | -13.16 Million | -10.59 Million |
| Earnings Per Share Basic | -0.10 | -0.07 | -0.15 | -0.16 | -0.19 | -0.18 |
| Earnings Per Share Diluted | -0.10 | -0.07 | -0.15 | -0.16 | -0.19 | -0.18 |
| Weighted Average Shares Outstanding | 91.68 Million | 89.38 Million | 81.97 Million | 73.82 Million | 68.84 Million | 60.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.68 Million | 89.38 Million | 81.97 Million | 73.82 Million | 68.84 Million | 60.46 Million |
| Gross Margin | - | - | - | -1.60 | 0.42 | 0.53 |
| EBIT Margin | - | - | - | -2342.20 | -114.79 | -35.58 |
| Profit Margin | - | - | - | -2347.60 | -113.47 | -35.43 |
| EBITDA | -8.77 Million | -6.52 Million | -12.49 Million | -11.71 Million | -13.11 Million | -10.57 Million |
| Earnings Before Tax Margin | - | - | - | -2344.00 | -114.87 | -35.59 |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 3000.00 | 3000.00 | 2000.00 | 3000.00 | 12 Thousand | 3000.00 |
| Gross Profit | -3000.00 | -3000.00 | -2000.00 | -3000.00 | -12 Thousand | -3000.00 |
| Operating Expenses | 4.85 Million | 1.01 Million | 1.09 Million | 1.38 Million | 6.64 Million | -1.67 Million |
| Selling, General and Administrative Expenses | 2.83 Million | 353 Thousand | 505 Thousand | 665 Thousand | - | -1.67 Million |
| Research and Development Expenses | 2.02 Million | 658 Thousand | 592 Thousand | 717 Thousand | - | -2.26 Million |
| Other Expenses | - | - | - | - | 113 Thousand | -3 Million |
| Cost and Expenses | 4.85 Million | 1.01 Million | 1.09 Million | 1.38 Million | 6.65 Million | -1.67 Million |
| Operating Income | -4.85 Million | -1.01 Million | -1.09 Million | -1.38 Million | -6.65 Million | 1.67 Million |
| Interest Expense | - | - | - | 2000.00 | 43 Thousand | - |
| Income Tax Expense | -430 Thousand | 1.00 | - | - | -1.00 | - |
| Earnings before Tax | -5.31 Million | -1.03 Million | -1.11 Million | -1.38 Million | -6.57 Million | -1.33 Million |
| Net Income | -5.31 Million | -1.03 Million | -1.11 Million | -1.38 Million | -6.57 Million | -1.33 Million |
| Earnings Per Share Basic | -0.06 | -0.01 | -0.01 | -0.02 | - | -0.01 |
| Earnings Per Share Diluted | -0.06 | -0.01 | -0.01 | -0.02 | - | -0.01 |
| Weighted Average Shares Outstanding | 92.15 Million | 92.15 Million | 91.26 Million | 90.51 Million | 89.38 Million | 90.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 92.15 Million | 92.15 Million | 91.26 Million | 90.51 Million | 89.38 Million | 90.51 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -5.27 Million | -1.01 Million | -1.09 Million | -1.38 Million | - | 1.67 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
003030
4132
ATLPF
6195
005010
PINF